Talimogene laherparepvec

IMLYGIC 1x10e6 UFP/ml solucion inyectable

300000-3000000 Unidades formadoras de placa solución inyectableSpainAuthorisedAuthorised 22 Jan 2016

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ImlygicEuropean UnionAuthorised

ImlygicEuropean Union · Amgen Europe B.V.Same brand
ImlygicCroatiaSame brand
ImlygicItaly · Soluzione iniettabile · Amgen Europe B.V.Same brand
Imlygic 106 plaquevormende eenheden (PFU)/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Amgen Europe B.V.Same brand
Imlygic 108 plaquevormende eenheden (PFU)/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Amgen Europe B.V.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Talimogene laherparepvec

IMLYGIC 1x10e6 UFP/ml solucion inyectable

300000-3000000 Unidades formadoras de placa solución inyectableSpainAuthorisedAuthorised 22 Jan 2016

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ImlygicEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ImlygicUnited States · 100 MILLION PFU/ML · For Injection · Amgen Inc.

ImlygicUnited States · 1 MILLION PFU/ML · For Injection · Amgen Inc.

Packs

Pack	Code	Status
IMLYGIC 1x10e6 UFP/ml solucion inyectable 1 ml	709763

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Talimogene laherparepvec
Strength: 300000-3000000 Unidades formadoras de placa
Dosage form: solución inyectable
Route: vía intralesional
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 22 Jan 2016
Registration: 1151064001
Marketing authorisation holder: Amgen Europe B.V.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/15/1064